Form 4: LifeStance Health CFO Reports Stock Transactions Following RSU Vesting

David Bourdon, CFO of LifeStance Health Group, reports acquisition and disposal of common stock related to vesting of restricted stock units and subsequent sale to cover tax obligations.

Summary

• David Bourdon, the Chief Financial Officer of LifeStance Health Group, reported transactions involving the company's common stock.
• On March 8, 2024, Bourdon acquired 104,022 restricted stock units (RSUs) and 124,644 performance-based restricted stock units that vested.
• Following these acquisitions, Bourdon beneficially owned 492,682 shares of common stock.
• On March 11, 2024, Bourdon sold 58,826 shares at a price of $6.93 per share to cover tax withholding obligations related to the vesting of the RSUs, resulting in a holding of 433,856 shares.
• The sale was executed as a 'sell to cover' transaction to satisfy tax obligations and was not a discretionary trade.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, as it's a factual report of events related to executive compensation.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It reflects the standard practice of granting and vesting RSUs as part of executive compensation packages.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares, but the impact is likely minimal as it is related to tax obligations.

Key Dates